FDA, EU authorities update guidance on clinical trials during COVID-19

The European Commission and European Medicines Agency (EMA) on Tuesday updated their guidance on managing clinical trials during the coronavirus disease (COVID-19) pandemic, adding advice on distribution, data verification and communicating with authorities.

The updated guidance follows a recent similar update from the US Food and Drug Administration (FDA), which added seven new questions and answers to its document.